Principles for antimicrobial prophylaxis of surgical site infections (SSIs)
Last reviewed November 2020
Dosing and re-dosing recommendations for antimicrobials commonly used for surgical prophylaxis
Antimicrobial |
Adult dose | Pediatric dose* (max dose should not exceed the recommended adult dose) |
Intra-operative re-dosing (from time of administration of pre-op dose) |
---|---|---|---|
Cefazolin | 2 g Consider 3g if weight above 120kg |
30 mg/kg/dose |
Every 4 h (Max 6 g / 24h) |
Aminoglycoside: Gentamicin or Tobramycin |
2.5 mg/kg (Round to nearest 20 mg) |
2.5 mg/kg/dose Max 120mg/dose |
At 6h x 1 (if CrCl ≥ 60 ml/min) Pediatrics: none required |
Metronidazole | 500 mg | 15 mg/kg/dose Max 500mg/dose |
At 12 hrs x 1 Pediatrics: see IWK Spectrum App |
Vancomycin |
15 mg/kg round nearest 250mg Administer: ≤1g over 60 min, |
15 mg/kg/dose |
At 12h x 1 (if CrCl ≥ 60 ml/min) Pediatrics: see IWK Spectrum App |
*For more detailed pediatric recommendations, please refer to the IWK Spectrum App
Last reviewed November 2020
Systemic surgical prophylaxis recommendations:
Note: for detailed pediatric recommendations, please refer to the IWK Spectrum App
Type of Surgery | Recommended Antimicrobial(s) |
Alternative Antimicrobial(s) if anaphylaxis to cefazolin or severe delayed reaction to any beta-lactam such as SJS/TEN, DRESS, AGEP |
---|---|---|
Cardiac | ||
Coronary artery bypass (CABG), |
cefazolin | vancomycin |
Ventricular assist devices Device insertion (e.g. pacemaker) |
cefazolin | vancomycin |
Cardiac catheterization Transesophageal echocardiogram |
none | none |
General | ||
Gastroduodenal/esophageal | cefazolin | vancomycin + aminoglycoside |
PEG insertion | cefazolin | vancomycin |
Biliary tract- laparoscopic procedure- Low risk | none | none |
Biliary tract- laparoscopic procedure – High risk
|
cefazolin | vancomycin + aminoglycoside |
Biliary tract- open procedure | cefazolin | vancomycin + aminoglycoside |
Colorectal, small bowel, appendectomy Pancreaticoduodenectomy |
cefazolin + metronidazole |
vancomycin + aminoglycoside + metronidazole |
Hernia repair- Hernioplasty, herniorrhaphy | cefazolin | vancomycin |
Low risk anorectal procedures: hemorrhoidectomy, fistulotomy, sphincterotomy | none | none |
Thoracic | ||
Non-cardiac procedures (e.g. lobectomy, pneumonectomy, lung resection, and thoracotomy) Video-assisted thoracoscopic surgery |
cefazolin | vancomycin |
Thoracentesis or chest tube insertion for non-traumatic indications (e.g. spontaneous pneumothorax) | none | none |
Head and Neck | ||
Clean: no incision through oral/nasal/pharyngeal mucosa (e.g. parotidectomy, thyroidectomy, and submandibular gland excision) | none | none |
Clean with placement of prosthetic material (excludes tympanostomy tubes that do not require prophylaxis) | cefazolin | vancomycin |
Clean-contaminated (incision through oral/pharyngeal mucosa): cancer surgery and other clean-contaminated procedures with the exception of tonsillectomy and functional endoscopic sinus procedures | cefazolin + metronidazole |
vancomycin + metronidazole |
Neurosurgery | ||
Elective craniotomy, stereotactic brain biopsy, cerebrospinal fluid-shunting procedures, ICP monitor, external ventricular drain, and implantation of intrathecal pumps | cefazolin | vancomycin |
Orthopedic | ||
Arthroscopy without graft implantation | none | none |
Spinal procedures with and without instrumentation, hip fracture repair, Implantation of internal fixation devices (e.g., nails, screws, plates, wires), and total joint replacement | cefazolin | vancomycin |
Urologic | ||
In addition to the prophylaxis recommendations below, obtain urine culture prior to stone removal or invasive procedures involving mucosal bleeding/trauma. If bacteria are found in the culture, treat based on sensitivities prior to performing the procedure. | ||
Cystoscopy/Shock-wave lithotripsy
|
none | |
Cystoscopy/Shockwave lithotripsy: Risk factors: • Advanced age, immunocompromised, anatomic abnormalities, poor nutrition, diabetes mellitus, smoking, prolonged catheters • Manipulation (prostatectomy, biopsy, foreign body removal, urethral dilation, stent placement/removal, ureteroscopy) |
If no hospitalization in last year, recent give 1-2 hours pre-procedure If risk of Gram-negative bacteria resistance: |
|
Transrectal prostate biopsy |
Give 1-2 hours pre-procedure: If risk of Gram-negative bacteria resistance:
add |
|
Percutaneous renal surgery | cefazolin | vancomycin |
Open or Laparoscopic: without entry into bowel/vagina |
cefazolin | vancomycin + aminoglycoside |
Open or Laparoscopic: involving manipulation of bowel/vagina |
cefazolin + metronidazole |
vancomycin + aminoglycoside + metronidazole |
Arterial surgery Graft placement or repair |
cefazolin | vancomycin |
Vascular | ||
Arterial surgery Graft placement or repair |
cefazolin | vancomycin |
Plastics | ||
Clean without risk factors | none | none |
Clean - high risk
|
cefazolin | vancomycin |
Breast surgery | cefazolin | vancomycin |
Obstetrical/Gynecological | ||
Caesarean section | cefazolin | vancomycin + aminoglycoside |
Hysterectomy | cefazolin +/- metronidazole |
vancomycin + aminoglycoside +/- metronidazole |
Laparoscopic procedures that involve no direct access from the abdominal cavity to the uterine cavity or vagina | none | none |
Last reviewed November 2020
1. University of Toronto Best Practice in Surgery Program.http://bestpracticeinsurgery.ca/wp-content/uploads/2017/11/SSI-BPS-CPG-Nov20.pdf
2. World Health Organization. Global Guidelines for the Prevention of Surgical Site Infection.https://www.who.int/gpsc/ssi-prevention-guidelines/en/
Last reviewed November 2020